finish c · 2019-04-26 · p_¶{ ¡ { ² (! Ç!"#$ %&'$()*$ M ç ! Ç M M ! Ç ! Ç ç Ð § ZÓ! Ç
bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ...
Transcript of bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ...
Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 85
123456
32504051.2
46.91.9
20
25
6535
Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab JamahiriyaABSTRACT We studied the epidemiology of hepatitis B and C infection among a sample of patients referred to the Department of the Infectious and Endemic Diseases at Al Jamahiriya Hospital in Benghazi. Of a total 3250 patients, 40% were randomly selected. Of these, 51.2%were infected with hepatitis B virus, 46.9% with hepatitis C virus and 1.9% with hepatitis B and C. Younger patients and single patients were more prone to hepatitis B infection, while older patients, married patients and travellers were more prone to hepatitis C. About 20% of hepatitis B cases and 25% of hepatitis C cases were non-Libyans. Males were more affected (65%) than females (35%).
[email protected], [email protected], [email protected]/07/0508/02/06
(1) Huda Kutrani. Department of Information Technology, Faculty of Public Health, Garyounis University, Benghazi; (2) Abdulsalam El-Gatit. Departments of Surgery & Cardiovascular Unit, Faculty of Medicine, Omar Almokhtar University, Al Batnan Medical Center, Tobruq; (3) Amina Shekhteryea. Department of Health Administration, Faculty of Public Health, Garyounis University, Benghazi; (4) Yousef El-Gitait. Department of Health Administration, High Institute of Medical Technology, Misurata; (5) Omar Sudani. Faculty of Public Health, Garyounis University, Benghazi; (6) Saad Akoub. Al Batnan Medical Center, Tobruq, Libyan Arab Jamahiriya.
Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab JamahiriyaABSTRACT We studied the epidemiology of hepatitis B and C infection among a sample of patients referred to the Department of the Infectious and Endemic Diseases at Al Jamahiriya Hospital in Benghazi. Of a total 3250 patients, 40% were randomly selected. Of these, 51.2% were infected with hepatitis B virus, 46.9% with hepatitis C virus and 1.9% with hepatitis B and C. Younger patients and single patients were more prone to hepatitis B infection, while older patients, married patients and travellers were more prone to hepatitis C. About 20% of hepatitis B cases and 25% of hepatitis C cases were non-Libyans. Males were more affected (65%) than females (35%).
[email protected], [email protected], [email protected]
االستالم: 26/07/05؛ القبول: 08/02/06(1) Huda Kutrani. Department of Information Technology, Faculty of Public Health, Garyounis University, Benghazi; (2) Abdulsalam El-Gatit. Departments of Surgery & Cardiovascular Unit, Faculty of Medicine, Omar Almokhtar University, Al Batnan Medical Center, Tobruq; (3) Amina Shekhteryea. Department of Health Administration, Faculty of Public Health, Garyounis University, Benghazi; (4) Yousef El-Gitait. Department of Health Administration, High Institute of Medical Technology, Misurata; (5) Omar Sudani. Faculty of Public Health, Garyounis University, Benghazi; (6) Saad Akoub. Al Batnan Medical Center, Tobruq, Libyan Arab Jamahiriya.
Facteurs démographiques influant sur l’infection par les virus des hépatites B et C à Benghazi (Jamahiriya arabe libyenne)RÉSUMÉ Nous avons analysé l’épidémiologie des hépatites B et C dans un échantillon de patients adressés au Service des Maladies infectieuses et endémiques du Al Jamahiriya Hospital de Benghazi. Sur un total de 3250 patients, 40 % ont été sélectionnés par randomisation. Sur cet effectif sélectionné, 51,2 % étaient infectés par le virus de l’hépatite B, 46,9 % par le virus de l’hépatite C et 1,9 % par les deux virus B et C. Les patients les plus jeunes et les célibataires se sont avérés davantage sujets à l’hépatite B, tandis que l’âge, le mariage et la qualité de voyageur semblent prédisposer à l’hépatite C. Environ 20 % des cas d’hépatite B et 25 % des cas d’hépatite C n’étaient pas de nationalité libyenne. Ces infections touchent en plus forte proportion les hommes (65 %) que les femmes (35 %).
86 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007
2
8-16
2.42.780,000
160,000
]1[0.81.40.30.8
1.80.9-1.24.2
1.32.4
256.8]2[1.6]3[
20.5]3[
30444266
7.9540014847
336Lancet716.6
12.97
1300
19982002
2003
Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 87
3
Rapidenzyme-linked immunosorbent assay:
ELISAPCR87467.2ELISAPCR23217.9Rapid
19414.9
t-testP
1300
665
51.261046.9251.9
8628.540.7)0.05 <P
42.90.05 <P
315
154546
15450.05 <P460.05 < P
0.05 < P(
0.05 < P1
88 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007
4
117
529
19 14
295301
0 1015
0
100
200
300
400
500
600
<15 15-45 =>46
1
84265.8458.235
0.05 < P
46135.520415.7
246
18.936428.0
0.05 < P
171.30.60.05 < P1
91370.2
38729.80.05 < P
47036.219515.00.05 < P
42632.8
18414.20.05 < P
171.3
8
0.60.05 < P(1)
81851.3
48237.00.05 < P
34126.2324
24.92
4
117
529
19 14
295301
0 1015
0
100
200
300
400
500
600
<15 15-45 46
1
8426545835
0.05 < P
46135.4620415.7
246
18.9236428
0.05 < P
171.310.610.05 < P1
91370.23
38729.770.05 < P
47036.16
195150.05 < P
42632.77
18414.150.05 < P
171.31
8
0.610.05 < P1
Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 89
5
45735.2
15311.80.05 < P
201.6
50.41
101978.428121.60.05 < P
1249.5
54141.60.05 < P
15211.7458
35.20.05<P
50.4
201.51
56843.70.05<P36528.00.05 < P154
11.90.05<P14611.20.05<P89
6.90.05<P100.8
0.05<P
32525.00.05<P135
10.40.05<P826.30.05<P302.3
0.05<P60.460.05<P
23017.7
0.05<P22217.1
644.90.05<P584.5
322.50.05<P40.30.05<P
131.00.05<P80.60.05<P
30.20.05<P10.070.05<P
0.05<P1
90 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007
Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 91
7
101678.228421.90.05 < P
634.9
493.80.05 < P17
1.30.05 < P
806.20.05<P
493.80.05 < P171.3
30.22
2
17)1.3(17)1.3(3)0.2(
49)3.8(80)6.2(3)0.2(
63)4.8(49)3.8(3)0.2(
536)41.2(
464)35.7(
16)1.2(
665)51.2(
610)46.9(
25)1.9(
463.6
292.214
1.10.05 < P
40.33
86666.60.05 < P
21616.60.05 < P
18013.90.05 < P382.90.05 < P
7
101678.228421.90.05 < P
634.9
493.80.05 < P17
1.30.05 < P
806.20.05<P
493.80.05 < P171.3
30.22
2
17)1.3(17)1.3(3)0.2(
49)3.8(80)6.2(3)0.2(
63)4.8(49)3.8(3)0.2(
536)41.2(
464)35.7(
16)1.2(
665)51.2(
610)46.9(
25)1.9(
463.6
292.214
1.10.05 < P
40.33
86666.60.05 < P
21616.60.05 < P
18013.90.05 < P382.90.05 < P
8
1
2
3
101678.228421.90.05 < P
634.9
493.80.05 < P17
1.30.05 < P
806.20.05<P
493.80.05 < P171.3
30.22
2
17)1.3(17)1.3(3)0.2(
49)3.8(80)6.2(3)0.2(
63)4.8(49)3.8(3)0.2(
536)41.2(464)35.7(16)1.2(
665)51.2(610)46.9(25)1.9(
463.6
292.214
92 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007
8
43233.2)0.05 < P1118.5
0.05 < P98
7.50.05 < P241.90.05 < P
231.80.05 < P
0.070.0723
24
11198
432
10581
13
411
01 123
0
50
100
150
200
250
300
350
400
450
500
No.
of P
atie
nts
B C B & C
2
133130010.2116789.80.05 < P
312.466563448.80.05<P967.4
61051439.50.05 < P
60.46
25191.50.05 < P
7.4
2.40.05 < P
0.05 < P3
Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 93
9
584.51242
95.50.05 < P
292.263649.0
0.05 < P
292.258144.70.05 < P
0.05 < P3
3
29)2.2(14)1.1(4)0.3(
636)48.9(
596)45.8(21)1.6(
31)2.4(96)7.4(6)0.5(
634)48.8(
514)39.5(19)1.5(
29)2.2(29)2.2(0)0(
636)48.9(
581)44.7(25)1.9(
)1(P = 0.000
)2(
4
9
584.51242
95.50.05 < P
292.263649.0
0.05 < P
292.258144.70.05 < P
0.05 < P3
3
29)2.2(14)1.1(4)0.3(
636)48.9(
596)45.8(21)1.6(
31)2.4(96)7.4(6)0.5(
634)48.8(
514)39.5(19)1.5(
29)2.2(29)2.2(0)0(
636)48.9(
581)44.7(25)1.9(
)1(P = 0.000
)2(
4
94 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007
10
5
)3(
4
5
)4(9.511.7
45
)5(4
5
)6(2.4
37.430.05 < P
4
PdfWald S.E
0.893 10.018 0.597 0.08-
0.000 126.898 0.006 0.03-
0.023 15.161 0.14 0.318-
0.026 14.985 0.184 0.411
0.034 14.517 0.163 0.347-
0.000 122.335 0.243 1.147-
2= 290.639d.f = 16P = 0.000
Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 95
11
5
PdfWald S.E
0.787 10.073 0.601 0.163
0.000 127.578 0.006 0.031
0.037 14.355 0.140 0.293
0.018 15.577 0.185 0.438-
0.019 15.521 0.162 0.382
0.000 126.938 0.251 1.303
2= 298.195d.f = 16P = 0.000
ELISAPCR
Rapid
]38[
genotype
]910[
13
5
PdfWald S.E
0.787 10.073 0.601 0.163
0.000 127.578 0.006 0.031
0.037 14.355 0.140 0.293
0.018 15.577 0.185 0.438-
0.019 15.521 0.162 0.382
0.000 126.938 0.251 1.303
2= 298.195d.f = 16P = 0.000
ELISAPCR
Rapid
]38[
genotype
]910[
96 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007
References
1. Kane A, et al. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bulletin of the World Health Organization, 1999, 77:801–7.
2.
.1998
3. Daw MA et al. Prevalence of hepatitis C virus antibodies among different popula--
tions of relative and attributable risk. Saudi medical journal, 2002, 23(11):1356–60.
4. Daw MA et al. Seroepidemiology of hepatitis B virus markers among hos--p i t a l h e a l t h c a r e w o r k e r s . A n a l y --sis of certain potential risk factors. Saudi medical journal, 2000, 21(12): 1157–60.
5. Saleh MG et al. High prevalence of hepa--titis C virus in the normal Libyan popula--tion. Transactions of the Royal Society
14
]3-5[
clinical audits
References
1. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bulletin of the World Health Organization, 1999, 77:801 7.
2.1998
3. Daw MA et al. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi medical journal, 2002, 23(11):1356–60.
4. Daw MA et al. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors. Saudi medical journal, 2000, 21(12): 1157–60.
5. Saleh MG et al. High prevalence of hepatitis C virus in the normal Libyan population. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 88(3):292–4.
6. Yerly S et al. Nosocomial outbreak of multiple bloodborne viral infections. Journal ofinfectious diseases, 2001, 184(3):369–72.
7. Wyatt GB. Pregnancy hepatitis in Libya. Lancet, 197, 1(8023):1204–5.
8. Hong Z et al. Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992–2003. European journal of clinical microbiology & infectious diseases, 2005, 24(7):464–70.
9. Okamoto K et al. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. Journal ofgastroenterology and hepatology, 2005, 20(7):1102–8.
10. Verschuere V, Yap PS, Fevery J. Is HBV genotyping of clinical relevance? Acta gastro-enterologica Belgica, 2005, 68(2):233–6.
11. Chiaramonte M et al. Risk factors in community-acquired chronic hepatitis C virus infection: a case–control study in Italy. Journal of hepatology, 1996, 24:129 34.
12
]1112[
]34[
]6[
3
]3-5[
clinical audits
Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 97
of Tropical Medicine and Hygiene, 1994, 88(3):292–4.
6. Yerly S et al. Nosocomial outbreak of mul--tiple bloodborne viral infections. Journal of infectious diseases, 2001, 184(3):369–72.
7. Wyatt GB. Pregnancy hepatitis in Libya. Lancet, 197, 1(8023):1204–5.
8. Hong Z et al. Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992–2003. European journal of clinical microbiology & infectious dis--eases, 2005, 24(7):464–70.
9. Okamoto K et al. Association of functional gene polymorphisms of matrix metallo--proteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. Journal of gastroenterology and hepatology, 2005, 20(7):1102–8.
10. Verschuere V, Yap PS, Fevery J . Is HBV genotyping of clinical relevance? Acta gastro-enterologica Belgica, 2005, 68(2):233–6.
11. Chiaramonte M et al. Risk factors in com--munity-acquired chronic hepatitis C virus infection: a case–control study in Italy. Journal of hepatology, 1996, 24:129–34.